glp 1 antagonist drugs The GLP-1 Agonists and Obesity: How Diabetes are Changing Non-Diabetic Lives — tl;dr pharmacy GLP-1 Medications for Weight Loss:
Description
doi: 10.4239/wjd.v4.i5.190
eGastroenterology 2 (1), e100036
Experts say a less expensive version of these GLP-1 medications would give more people access to these effective weight-loss drugs
Approximately 15-40% of individuals diagnosed with IBD and an additional 20-40% are estimated to be obese and overweight respectively ( Table 1 )
Here is a small sampling of the research evidence: A 2012 meta-analysis examined 25 randomized controlled trials and found that GLP-1 receptor agonist treatment caused weight loss
The first encouraging human signal came from Athauda and colleagues in 2017
